Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001721020-26-000004

Director acquired 7,142 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Seth Alpna Director 2026-06-03 Grant or award +7,142 12,392 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Seth Alpna Director 2026-06-03 Grant or award · Stock Option (right to buy) +7,433 7,433 D: show line 2 in the form
Loading xslF345X06/form4-06052026_090614.xml…